Researchers have been using liposomes to selectively deliver toxic payloads like cisplatin to cancer cells for years. But recently-announced studies at the University of Illinois at Urbana-Champaign (UIUC) resulted in a molecule that,...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)